Verve Therapeutics shares owned by Martingale Asset Management
Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Martingale Asset Management
from 13F filings
Historical chart of Martingale Asset Management investment in Verve Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Verve Therapeutics held by Martingale Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Verve Therapeutics by Martingale Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $565k | 50k | 11.23 |
| 2025-03-31 | $230k | 50k | 4.57 |
| 2024-12-31 | $284k | 50k | 5.64 |
| 2024-09-30 | $244k | 50k | 4.84 |
| 2024-06-30 | $246k | 50k | 4.88 |
| 2024-03-31 | $385k | 29k | 13.28 |
| 2023-12-31 | $393k | 28k | 13.94 |
| 2023-09-30 | $271k | 20k | 13.26 |
| 2023-03-31 | $235k | 16k | 14.42 |
| 2022-12-31 | $315k | 16k | 19.35 |
| 2022-09-30 | $559k | 16k | 34.35 |
More positions owned by Martingale Asset Management
View all positions for Martingale Asset Management